Guardian Pharmacy [GRDN] vs HCA Healthcare [HCA] Detailed Stock Comparison
Guardian Pharmacy
NYSE
Loading...
HCA Healthcare
NYSE
Loading...
TLDR: Quick Comparison Summary
Based on 20 vital metrics comparison: Guardian Pharmacy wins in 5 metrics, HCA Healthcare wins in 13 metrics, with 0 ties. HCA Healthcare appears stronger overall.
View Metrics Details
Vital Metrics Comparison
| Metric | Guardian Pharmacy | HCA Healthcare | Better |
|---|---|---|---|
| P/E Ratio (TTM) | 90.13 | 18.04 | HCA Healthcare |
| Price-to-Book Ratio | 8.94 | -81.93 | HCA Healthcare |
| Debt-to-Equity Ratio | 22.18 | -37.45 | HCA Healthcare |
| PEG Ratio | -6.39 | 0.72 | Guardian Pharmacy |
| EV/EBITDA | -41.96 | 10.28 | Guardian Pharmacy |
| Profit Margin (TTM) | -5.19% | 8.21% | HCA Healthcare |
| Operating Margin (TTM) | 4.38% | 15.95% | HCA Healthcare |
| EBITDA Margin (TTM) | 4.38% | 15.95% | HCA Healthcare |
| Return on Equity | -52.74% | 13,631.68% | HCA Healthcare |
| Return on Assets (TTM) | -10.92% | 11.84% | HCA Healthcare |
| Free Cash Flow (TTM) | $41.59M | $5.64B | HCA Healthcare |
| Dividend Yield | N/A | 0.54% | N/A |
| 1-Year Return | 37.90% | 9.00% | Guardian Pharmacy |
| Price-to-Sales Ratio (TTM) | 1.14 | 1.38 | Guardian Pharmacy |
| Enterprise Value | $1.55B | $148.99B | HCA Healthcare |
| EV/Revenue Ratio | 1.17 | 2.05 | Guardian Pharmacy |
| Gross Profit Margin (TTM) | 19.79% | 40.97% | HCA Healthcare |
| Revenue per Share (TTM) | $21 | $292 | HCA Healthcare |
| Earnings per Share (Diluted) | $-1.48 | $23.81 | HCA Healthcare |
| Beta (Stock Volatility) | N/A | 1.41 | N/A |
Performance
News Sentiment
Key Stats
Valuation
Financials
Short Interest
Dividends
Guardian Pharmacy vs HCA Healthcare Stock Performance Analysis
Loading Price Chart...
Performance Comparison
Short-term Returns
| Stock | 1D | 1W | 1M | 3M | 6M | YTD |
|---|---|---|---|---|---|---|
| Guardian Pharmacy | -0.84% | -7.96% | -15.73% | 14.82% | 11.14% | 20.36% |
| HCA Healthcare | 0.93% | 2.50% | 5.38% | 14.06% | 23.03% | 44.26% |
Long-term Returns
| Stock | 1Y | 3Y | 5Y | 10Y | 15Y | 20Y |
|---|---|---|---|---|---|---|
| Guardian Pharmacy | 37.90% | 34.87% | 34.87% | 34.87% | 34.87% | 34.87% |
| HCA Healthcare | 9.00% | 114.28% | 220.65% | 451.33% | 1,280.27% | 1,280.27% |
News Based Sentiment: Guardian Pharmacy vs HCA Healthcare
Guardian Pharmacy
News based Sentiment: MIXED
Guardian Pharmacy Services had a month of contrasts, with strong Q2 financial results and positive analyst coverage offset by significant insider selling and valuation concerns. The raised guidance and operational improvements are encouraging, but the insider activity and DCF valuation create uncertainty for investors.
HCA Healthcare
News based Sentiment: MIXED
HCA Healthcare reported strong Q2 2025 results and is expanding its operations, but faces regulatory challenges and mixed investor sentiment. While analysts generally maintain positive ratings, insider selling and slowing outpatient growth introduce caution, creating a mixed investment narrative.
Performance & Financial Health Analysis: Guardian Pharmacy vs HCA Healthcare
| Metric | GRDN | HCA |
|---|---|---|
| Market Information | ||
| Market Cap | $1.52B | $100.93B |
| Market Cap Category | Small cap | Large cap |
| 10 Day Avg. Volume | 319,010 | 1,035,510 |
| 90 Day Avg. Volume | 397,023 | 1,206,980 |
| Last Close | $23.74 | $433.55 |
| 52 Week Range | $16.50 - $30.39 | $289.98 - $435.03 |
| % from 52W High | -21.88% | -0.34% |
| All-Time High | $30.39 (Sep 12, 2025) | $435.03 (Oct 06, 2025) |
| % from All-Time High | -21.88% | -0.34% |
| Growth Metrics | ||
| Quarterly Revenue Growth | 0.15% | 0.06% |
| Quarterly Earnings Growth | -0.15% | 0.13% |
| Financial Health | ||
| Profit Margin (TTM) | -0.05% | 0.08% |
| Operating Margin (TTM) | 0.04% | 0.16% |
| Return on Equity (TTM) | -0.53% | 136.32% |
| Debt to Equity (MRQ) | 22.18 | -37.45 |
| Cash & Liquidity | ||
| Book Value per Share (MRQ) | $2.68 | $-18.61 |
| Cash per Share (MRQ) | $0.30 | $4.45 |
| Operating Cash Flow (TTM) | $57.66M | $11.93B |
| Levered Free Cash Flow (TTM) | $87.15M | $5.59B |
| Dividends | ||
| Last 12-Month Dividend Yield | N/A | 0.54% |
| Last 12-Month Dividend | N/A | $2.04 |
Valuation & Enterprise Metrics Analysis: Guardian Pharmacy vs HCA Healthcare
| Metric | GRDN | HCA |
|---|---|---|
| Price Ratios | ||
| P/E Ratio (TTM) | 90.13 | 18.04 |
| Forward P/E | 27.52 | 17.50 |
| PEG Ratio | -6.39 | 0.72 |
| Price to Sales (TTM) | 1.14 | 1.38 |
| Price to Book (MRQ) | 8.94 | -81.93 |
| Market Capitalization | ||
| Market Capitalization | $1.52B | $100.93B |
| Enterprise Value | $1.55B | $148.99B |
| Enterprise Value Metrics | ||
| Enterprise to Revenue | 1.17 | 2.05 |
| Enterprise to EBITDA | -41.96 | 10.28 |
| Risk & Other Metrics | ||
| Beta | N/A | 1.41 |
| Book Value per Share (MRQ) | $2.68 | $-18.61 |
Financial Statements Comparison: Guardian Pharmacy vs HCA Healthcare
Financial Metrics
Loading Financial Charts...
Revenue
EBITDA
Operating Margin
Free Cash Flow
Long Term Debt
Profit Margin
Current Ratio
Operating Cash Flow
Income Statement (MRQ)
| Metric (MRQ) | GRDN | HCA |
|---|---|---|
| Revenue/Sales | $329.31M | $18.61B |
| Cost of Goods Sold | $264.96M | $10.98B |
| Gross Profit | $64.35M | $7.62B |
| Research & Development | N/A | N/A |
| Operating Income (EBIT) | $13.01M | $2.97B |
| EBITDA | $18.54M | $3.85B |
| Pre-Tax Income | $13.11M | $2.42B |
| Income Tax | $3.83M | $524.00M |
| Net Income (Profit) | $9.27M | $1.89B |
Balance Sheet & Liquidity Metrics (MRQ)
| Metric (MRQ) | GRDN | HCA |
|---|---|---|
| Cash & Equivalents | $14.00M | $1.06B |
| Total Current Assets | $166.04M | $16.26B |
| Total Current Liabilities | $145.30M | $13.63B |
| Long-Term Debt | $21.79M | $42.92B |
| Total Shareholders Equity | $163.22M | $-438.00M |
| Retained Earnings | $26.57M | $-3.16B |
| Property, Plant & Equipment | $78.92M | $65.81B |
Cash Flow Statement Comparison (MRQ)
| Metric (MRQ) | GRDN | HCA |
|---|---|---|
| Operating Cash Flow | $20.61M | $2.65B |
| Capital Expenditures | $-5.81M | $-991.00M |
| Free Cash Flow | $11.75M | $660.00M |
| Debt Repayment | $-1.13M | $-3.90B |
| Common Stock Repurchase | N/A | $-2.51B |
Short Interest & Institutional Ownership Analysis
| Metric | GRDN | HCA |
|---|---|---|
| Shares Short | 536,606 | 4.23M |
| Short Ratio | 1.66 | 3.66 |
| Short % of Float | 0.04% | 0.03% |
| Average Daily Volume (10 Day) | 319,010 | 1,035,510 |
| Average Daily Volume (90 Day) | 397,023 | 1,206,980 |
| Shares Outstanding | 63.29M | 249.98M |
| Float Shares | 9.39M | 162.19M |
| % Held by Insiders | 0.61% | 0.01% |
| % Held by Institutions | 0.84% | 0.63% |
Dividend Analysis & Yield Comparison: Guardian Pharmacy vs HCA Healthcare
| Metric | GRDN | HCA |
|---|---|---|
| Last 12-Month Dividend | N/A | $2.04 |
| Last 12-Month Dividend Yield | N/A | 0.54% |
| 3-Year Avg Annual Dividend | N/A | $2.29 |
| 3-Year Avg Dividend Yield | N/A | 0.22% |
| 3-Year Total Dividends | N/A | $6.88 |
| Ex-Dividend Date | N/A | Mar 17, 2025 |